Lastly, the prescription of VDRA therapy was associated with a history of diabetes, baseline iPTH > 150 ng/l, serum albumin > 35 g/l, and abnormal calcium levels (≥ 2.6 mmol/L) (Table 2). The gene discussed is ALB; the disease is diabetes mellitus.